Search

Search Constraints

You searched for: Author/Creator Hubeaux, Stanislas

Search Results

1. 178 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis. Issue 12 (14th November 2019)

2. Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. (January 2017)

3. Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension. (29th September 2020)

4. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2020)